BeOne Medicines AG (BVMF:B1ME34)

BeOne Medicines AG Ratios and Metrics

Market cap in millions BRL. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 25, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	180,453	185,173	121,640	91,523	120,761	155,135
Market Cap Growth	31.28%	52.23%	32.91%	-24.21%	-22.16%	27.15%
Enterprise Value	162,727	168,556	111,360	79,776	97,661	137,209
Last Close Price	67.22	70.00	44.65	34.11	38.45	-
PE Ratio	114.18	117.17	-	-	-	-
PS Ratio	6.13	6.29	5.16	7.67	16.13	23.67
PB Ratio	7.51	7.71	5.90	5.33	5.21	4.54
P/TBV Ratio	7.62	7.82	5.99	5.42	5.26	4.58
P/FCF Ratio	34.79	35.70	-	-	-	-
P/OCF Ratio	29.06	29.82	-	-	-	-
EV/Sales Ratio	5.94	5.73	4.72	6.69	13.05	20.94
EV/EBITDA Ratio	53.32	52.87	-	-	-	-
EV/EBIT Ratio	73.38	68.44	-	-	-	-
EV/FCF Ratio	31.37	32.49	-	-	-	-
Debt / Equity Ratio	0.25	0.25	0.32	0.26	0.14	0.11
Debt / EBITDA Ratio	1.79	1.79	-	-	-	-
Debt / FCF Ratio	1.16	1.16	-	-	-	-
Net Debt / Equity Ratio	-0.79	-0.79	-0.46	-0.63	-0.90	-0.97
Net Debt / EBITDA Ratio	-5.97	-5.97	3.86	2.00	2.28	4.25
Net Debt / FCF Ratio	-3.67	-3.67	2.44	1.30	2.16	3.80
Asset Turnover	0.76	0.76	0.65	0.40	0.19	0.17
Inventory Turnover	1.21	1.21	1.30	1.09	1.09	0.99
Quick Ratio	2.97	2.97	1.51	1.97	3.22	4.45
Current Ratio	3.41	3.41	1.80	2.32	3.55	4.76
Return on Equity (ROE)	7.46%	7.46%	-18.77%	-22.26%	-38.11%	-29.15%
Return on Assets (ROA)	3.96%	3.96%	-6.06%	-12.39%	-15.00%	-12.72%
Return on Invested Capital (ROIC)	30.49%	22.87%	-36.89%	-138.75%	-549.14%	-
Return on Capital Employed (ROCE)	7.00%	7.00%	-15.30%	-30.20%	-36.40%	-20.70%
Earnings Yield	0.88%	0.85%	-3.28%	-4.67%	-8.77%	-5.24%
FCF Yield	2.87%	2.80%	-3.22%	-9.12%	-7.98%	-5.61%
Buyback Yield / Dilution	-7.75%	-7.75%	-0.86%	-1.22%	-11.15%	-11.16%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.